Suggested remit - To appraise the clinical and cost effectiveness of autologous haematopoietic stem cell transplantation (AHSTC) for previously treated relapsing-remitting multiple sclerosis.
Status Proposed
Process STA pre-2018
ID number 1111

Project Team

Project lead Michelle Adhemar

Email enquiries


Key events during the development of the guidance:

Date Update
27 July 2018 - 24 August 2018 Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators
16 August 2017 This topic is delayed pending further information
17 May 2017 (00:00) Scoping workshop (London)
28 March 2017 Draft scope documents

For further information on how we develop guidance, please see our page about NICE technology appraisal guidance